White Papers

Complimentary White Papers

Our complimentary white papers draw on our primary research findings to provide you information on critical life sciences topics. Please fill out the short form accompanying each white paper in the list below. You will then be directed to links to the downloadable PDFs.

Click a title below to get access to a white paper.

If you have questions, call (919) 403-6583.

• WP253: Electronic Medical Records
• WP252: Regulatory and Economic Impact on Commercial Funding of CME
• Executive Report: Looking Ahead to 2013
• WP251 Leveraging MSLs to Support Clinical Development
• WP236 MSL Hiring and Compensation
• WP250 Understanding the Importance of Mobile Health for Pharma
• WP249 Building a Global Launch Sequence in the Age of Austerity
• WP248 Key Trends in MSL Program Management
• WP246 Pricing Teams Weigh in Earlier
• WP245 Calling for a Chief Access Officer
• WP247 Counter Brand Revenue Erosion from Generics through Defensive Pricing Strategies
• WP244 Health Economics and Outcomes Research: Greater Resources Come with New Challenges
• WP243 Thought Leader Compensation: US vs. EU
• WP239 Targeting the Patient-Physician Touchpoint
• WP238 ePharma On the Go: There's an App for That
• WP237 Making Sense of Social Media in a Regulatory Vacuum
• WP234 In Defense of Pharma Medical Publications
• WP230 Investigator Compensation Scrutiny
• WP231 Targeted Therapies Drive Oncology's Promise
• WP232 Clinical Trial Transparency
• WP229 Global Clinical Outsourcing: Are China and India Ready for your Business?
• WP228 Top 6 Challenges for KOL Management
• WP225 Demonstrating MSL Programs’ ROI
• WP227 Boehringer Ingelheim: From Underdog To Giant
• WP226 Outcomes-Based Pricing: Meeting Payer Demands
• WP224 Thought Leader Training
• WP223 A Delicate Balance: Building Trust via Patient Education
• WP222 Drug Repurposing: Reviving Molecules, Preserving Brands
• WP220 The Changing Face of Pharmaceutical Market Research
• WP218 Clinical Diagnostics Marketing Budgets and Development Timelines
• WP221 Medical Affairs: Under Pressure
• WP219 Compensating Thought Leaders in a Compliance World
• WP203 Lifecycle Management’s Compromise in the Patent Wars
• WP202 The OTC Switch
• WP201 The New Competitive Intelligence Strategy
• WP204 Emerging Trends in the Cardiovascular Pharmaceutical Market
• WP205 Building Thought Leader Relationships
• WP206 Reprioritizing Investigator Meetings
• WP211 Web-Based Patient Recruitment
• WP210 Pharmaceutical Product Commercialization
• WP212 Investigator Initiated Trials
• WP213 Segmenting Target Physicians
• WP214 US Launch Marketing
• WP217 Medical Device Marketing: Maximizing Limited Resources
• WP216 Phase 4 Outsourcing: Reaching New Heights
• WP215 Pharma Customer Relationship Management
• WP233 Preferred Vendors A Good Decision